# US 2026/0262697 A1 · Nutritional Composition for Infants and/or Children and Methods for Making Same

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0262697 A1
- Document ID: US20260262697A1
- Status: Published application
- Kind: A1
- Application number: 19/662,708
- Filed: 2026-04-29
- Published: 2026-09-10
- Earliest claimed: 2021-04-30
- Assignees: Mead Johnson Nutrition Company
- Applicants: Mead Johnson Nutrition Company
- Inventors: John Daniel Alvey; Zihua Ao; Minhthy Le Nguyen
- Web page: https://patentgrep.com/patent/US20260262697A1

## CPC

- A23L 33/40: {Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula}
- A23C 21/02: containing, or treated with, microorganisms or enzymes
- A23C 21/06: Mixtures of whey with milk products or milk components
- A23C 21/08: containing other organic additives, e.g. vegetable or animal products
- A23J 1/205: {from whey, e.g. lactalbumine}
- A23J 3/08: Dairy proteins
- A61K 31/661: Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion {or mevinphos}
- A61K 35/20: Milk; Whey; Colostrum
- A23L: FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF (preservation thereof A23B)
- A23C: DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF (preservation thereof A23B11/00)
- A23J: PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

A synthetic nutritional composition for an infant and/or a child is described comprising a whey protein concentrate from milk, wherein the whey protein concentrate comprises: a milk fat content of between 6.5 to 10.0 wt %, wherein the milk fat contains components of milk fat globule membranes that provide at least 7 mg/g of sphingomyelin to the whey protein concentrate; and wherein the majority of the sphingomyelin in the synthetic nutritional composition is provided by the components of the milk fat globule membranes of the whey protein concentrate. Methods of making same are also described.

## Claims

### Claim 1

An infant formula comprising:
a synthetic infant nutritional composition comprising a whey protein concentrate from milk, wherein the whey protein concentrate comprises a milk fat content of between 6.5 to 10.0 wt %, wherein the milk fat comprises components of milk fat globule membranes that provide at least 7 mg/g of sphingomyelin to the whey protein concentrate;
wherein a majority of the sphingomyelin in the synthetic infant nutritional composition is provided by the components of the milk fat globule membranes of the whey protein concentrate;
wherein the synthetic infant nutritional composition has a whey protein to casein protein ratio in a range of from 60:40 to 100:0 on a dry weight basis; and
wherein the infant formula does not contain an enriched milk product or an enriched whey protein extract.

### Claim 2 (depends on 1)

The infant formula according to claim 1, wherein the whey protein concentrate comprises a milk fat content of between 7.5 to 10.0 wt %.

### Claim 3 (depends on 1)

The infant formula according to claim 1, wherein the whey protein concentrate comprises a milk fat content of between 8.5 to 10.0 wt %.

### Claim 4 (depends on 1)

The infant formula according to claim 1, wherein the whey protein concentrate comprises a milk fat content of between 9.0 to 10.0 wt %.

### Claim 5 (depends on 1)

The infant formula according to claim 1, wherein the whey protein concentrate comprises a milk fat content of 9.5 wt % (+/−0.3 wt %).

### Claim 6 (depends on 1)

The infant formula according to claim 1, wherein the whey protein concentrate comprises a sphingomyelin content of between 8.0 to 10.7 mg/g.

### Claim 7 (depends on 1)

The infant formula according to claim 1, wherein the whey protein concentrate comprises a sphingomyelin content of between 9.1 to 10.7 mg/g.

### Claim 8 (depends on 1)

The infant formula according to claim 1, wherein the whey protein concentrate comprises a sphingomyelin content of between 9.6 to 10.7 mg/g.

### Claim 9 (depends on 1)

The infant formula according to claim 1, wherein the whey protein concentrate comprises a sphingomyelin content of 10.2 mg/g (+/−0.3 mg/g).

### Claim 10 (depends on 1)

The infant formula according to claim 1, wherein the synthetic infant nutritional composition comprises between 6.5 to 12.0 wt % of the whey protein concentrate on a dry weight basis.

### Claim 11 (depends on 1)

The infant formula according to claim 1, wherein the components of the milk fat globule membranes of the whey protein concentrate provide at least 65% of the sphingomyelin of the total amount of sphingomyelin in the synthetic infant nutritional composition.

### Claim 12 (depends on 1)

The infant formula according to claim 1, wherein the synthetic infant nutritional composition comprises at least 0.74 mg/g of sphingomyelin on a dry weight basis.

### Claim 13 (depends on 1)

The infant formula according to claim 1, wherein the whey protein concentrate further comprises a total phospholipids content of between 25 to 50 mg/g.

### Claim 14 (depends on 1)

The infant formula according to claim 1, wherein the whey protein concentrate further comprises a ganglioside GD3 in an amount of between 700 to 2000 mg/Kg.

### Claim 15 (depends on 1)

The infant formula according to claim 1, wherein the whey protein concentrate further comprises a ganglioside GD3 in an amount of between 10 to 50 mg/Kg.

### Claim 16 (depends on 1)

The infant formula according to claim 1, wherein the synthetic infant nutritional composition further comprises one or more prebiotic(s) in the form of (i) at least one human milk oligosaccharide (HMO) and/or (ii) polydextrose (PDX) and/or (iii) galactooligosaccharide (GOS).

### Claim 17 (depends on 1)

The infant formula according to claim 1, wherein the synthetic infant nutritional composition has a whey protein to casein protein ratio in a range of from 60:40 to 70:30 on a dry weight basis.

### Claim 18 (depends on 1)

The infant formula according to claim 1, wherein the synthetic infant nutritional composition has a whey protein to casein protein ratio of about 60:40 on a dry weight basis.

### Claim 19

An infant formula comprising:
a synthetic infant nutritional composition comprising:
a whey protein concentrate from milk, wherein the whey protein concentrate comprises:
a milk fat content of between 7.5 to 10.0 wt %, wherein the milk fat comprises components of milk fat globule membranes that provide a sphingomyelin content of between 8.0 to 10.7 mg/g to the whey protein concentrate;
a total phospholipids content of between 25 to 50 mg/g; and
ganglioside GD3 in an amount of between 700 to 2000 mg/Kg; and
one or more prebiotic(s) in the form of (i) at least one human milk oligosaccharide (HMO) and/or (ii) polydextrose (PDX) and/or (iii) galactooligosaccharide (GOS);
wherein the components of the milk fat globule membranes of the whey protein concentrate provide at least 65% of the total amount of sphingomyelin in the synthetic infant nutritional composition;
wherein the synthetic infant nutritional composition has a whey protein to casein protein ratio in a range of from 60:40 to 100:0 on a dry weight basis; and
wherein the infant formula does not contain an enriched milk product or an enriched whey protein extract.

### Claim 20 (depends on 1)

The infant formula according to claim 1, wherein the synthetic infant nutritional composition has a whey protein to casein protein ratio in a range of from 60:40 to 70:30 on a dry weight basis.
